Literature DB >> 4006388

An autopsy case with Good's syndrome and dermatomyositis.

H Sakuma, H Yoshida, R Kasukawa, N Satoh, K Yoshino.   

Abstract

A 31-year-old male patient complaining of repeated respiratory infections was revealed to be in an immunodeficient state in both humoral and cellular immunity and accompanied by dermatomyositis which was proved by both clinical and histological findings. Persistent diarrhea followed by colonic bleeding due to multiple ulcers and a severe liver dysfunction seemed to bring him to his death. The autopsy revealed the presence of thymoma of spindle cell type, depleted cells in the systemic lymphatic systems and inflammatory lesions in the muscle, liver, lung, kidney and gastrointestinal tract. This is the first report of Good's syndrome accompanied by dermatomyositis.

Entities:  

Mesh:

Year:  1985        PMID: 4006388     DOI: 10.1007/bf02032294

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Collagen disease in patients with congenital agammaglobulinemia.

Authors:  J M CRAIG; D GITLIN; D S GRICE; C A JANEWAY
Journal:  Trans Assoc Am Physicians       Date:  1956

2.  Agammaglobulinemia.

Authors:  O C BRUTON
Journal:  Pediatrics       Date:  1952-06       Impact factor: 7.124

Review 3.  The spectrum of diseases associated with thymoma. Coincidence or syndrome?

Authors:  J V Souadjian; P Enriquez; M N Silverstein; J M Pépin
Journal:  Arch Intern Med       Date:  1974-08

4.  Meeting report of the Second International Workshop on Primary Immunodeficiency Disease in Man held in St. Petersburg, Florida, February, 1973.

Authors:  M D Cooper; W P Faulk; H H Fudenberg; R A Good; W Hitzig; H G Kunkel; I M Roitt; F S Rosen; M Seligmann; J F Soothill
Journal:  Clin Immunol Immunopathol       Date:  1974-04

5.  Panhypoplasia of the bone marrow. I. Demonstration of a plasma factor with anti-erythropoietin-like activity.

Authors:  J H Jepson; L Lowenstein
Journal:  Can Med Assoc J       Date:  1968-07-20       Impact factor: 8.262

6.  Studies on red cell aplasia. II. Report of a second patient with an antibody to erythroblast nuclei and a remission after immunosuppressive therapy.

Authors:  S B Krantz; V Kao
Journal:  Blood       Date:  1969-07       Impact factor: 22.113

7.  Immunodeficiency with thymoma: failure to induce Ig production in immunodeficient lymphocytes cocultured with normal T cells.

Authors:  S D Litwin
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

8.  Syndrome of neutrophil agranulocytosis, hypogammaglobulinemia, and thymoma.

Authors:  L Degos; A Faille; M Housset; L Boumsell; C Rabian; T Parames
Journal:  Blood       Date:  1982-10       Impact factor: 22.113

9.  Campylobacter colitis.

Authors:  M E Lambert; P F Schofield; A G Ironside; B K Mandal
Journal:  Br Med J       Date:  1979-03-31

10.  Acute colitis and bacteremia due to Campylobacter fetus.

Authors:  R Longfield; J O'Donnell; W Yudt; C Lissner; T Burns
Journal:  Dig Dis Sci       Date:  1979-12       Impact factor: 3.199

View more
  3 in total

1.  Thymoma with chronic diarrhea: report of two cases and review of the literature.

Authors:  Ozcan Yildiz; Mustafa Ozguroglu; Hande Turna; Teoman Yanmaz; Kamil Kaynak; Canan Akman; Sibel Erdamar Cetin; Buge Oz; Aykut Celik
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 2.  Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence.

Authors:  Theodoros Kelesidis; Otto Yang
Journal:  Clin Immunol       Date:  2010-02-10       Impact factor: 3.969

3.  Successful resection of dermatomyositis associated with thymic carcinoma: report of a case.

Authors:  Fumiyuki Takahashi; Koji Tsuta; Tetsutaro Nagaoka; Hideaki Miyamoto; Yuichi Saito; Hirofumi Amano; Koji Uchida; Yoshiteru Morio; Kazue Shimizu; Shinichi Sasaki; Shigeru Tominaga; Toshimasa Uekusa; Hiroshi Izumi; Yoichi Anami; Yoshihiro Matsuno; Kazuhisa Takahashi; Yoshinosuke Fukuchi
Journal:  Surg Today       Date:  2008-02-29       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.